FDA recall D-0377-2021
Teva Pharmaceuticals USA · Class II · drug
Product
Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial, Rx Only, TEVA Parenteral Medicines, Inc. Irvine, CA 92618 NDC 0703-4502-04
Reason for recall
Lack of Assurance of Sterility
Distribution
Product was distributed nationwide.
Key facts
- Status
- Terminated
- Initiation date
- 2021-04-26
- Report date
- 2021-05-26
- Termination date
- 2024-06-04
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Parsippany, NJ, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0377-2021